The research focuses on the unique immunology of brain tumors. The brain is a unique immune organ that is usually regarded as 'immunologically privileged', i.e. the immune system monitors it less-stringently than it does other organs. Utilizing the discrepancy between the immune surveillance inside and outside the brain, the lab has developed a novel method to treat brain tumors using a concept we termed 'Split Immunity'.
'Split immunity' as well as other basic-scientific and clinical questions regarding the unique immunology of brain tumors are being studied in the lab using various human and animal models.
Ilan Volovitz PhD
The Cancer Immunotherapy lab, The Neurosurgery department,
Tel-Aviv Sourasky Medical Canter